- Home
- TFIN vs TSHA Comparison
TFIN vs TSHA Comparison
Compare TFIN & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- TSHA
- Stock Information
- Founded
- TFIN 1981
- TSHA 2019
- Country
- TFIN United States
- TSHA United States
- Employees
- TFIN N/A
- TSHA N/A
- Industry
- TFIN Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- TFIN Finance
- TSHA Health Care
- Exchange
- TFIN Nasdaq
- TSHA Nasdaq
- Market Cap
- TFIN 1.2B
- TSHA 1.4B
- IPO Year
- TFIN N/A
- TSHA 2020
- Fundamental
- Price
- TFIN $58.72
- TSHA $4.99
- Analyst Decision
- TFIN Buy
- TSHA Strong Buy
- Analyst Count
- TFIN 4
- TSHA 9
- Target Price
- TFIN $62.00
- TSHA $10.00
- AVG Volume (30 Days)
- TFIN 298.4K
- TSHA 11.4M
- Earning Date
- TFIN 10-15-2025
- TSHA 11-04-2025
- Dividend Yield
- TFIN N/A
- TSHA N/A
- EPS Growth
- TFIN N/A
- TSHA N/A
- EPS
- TFIN 0.28
- TSHA N/A
- Revenue
- TFIN $412,291,000.00
- TSHA $8,098,000.00
- Revenue This Year
- TFIN $10.80
- TSHA N/A
- Revenue Next Year
- TFIN $11.33
- TSHA N/A
- P/E Ratio
- TFIN $209.03
- TSHA N/A
- Revenue Growth
- TFIN 3.78
- TSHA N/A
- 52 Week Low
- TFIN $42.90
- TSHA $1.05
- 52 Week High
- TFIN $110.58
- TSHA $5.51
- Technical
- Relative Strength Index (RSI)
- TFIN 60.54
- TSHA 60.65
- Support Level
- TFIN $57.24
- TSHA $4.70
- Resistance Level
- TFIN $61.26
- TSHA $5.33
- Average True Range (ATR)
- TFIN 2.73
- TSHA 0.37
- MACD
- TFIN 1.27
- TSHA -0.07
- Stochastic Oscillator
- TFIN 82.87
- TSHA 51.94
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.